ArticleScientific reports2025
Anticancer effect of piperine, a black pepper compound, regulating apoptosis mediated through extracellular vesicles and cathepsin D in acute leukemia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Piperine as a Multifunctional Epigenetic Modulator: Integrative Molecular Insights into Cancer and Chronic Disease Therapy.International journal of molecular sciences · 2026Review
- Mechanistic Insights into Piperine-Driven Oxidative Stress, Autophagy Activation and Anti-Migration Effects in Caco-2 Cells.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) contribute to tumorigenesis in acute leukemia, while natural compounds can counteract these EVs-mediated mechanisms. Piperine, a natural black pepper compound, exerts anticancer activity toward many cancer cells with minimal effect in normal PBMC cells via the apoptosis signaling pathway, a key programmed cell death pathway. The aim of this study was to investigate the involvement of EVs in piperine-induced apoptosis in acute leukemia. NB4 and MOLT-4 leukemic cell lines were treated with various concentrations of piperine. Cell viability, apoptosis, and cell cycle distribution were assessed using MTT assays and flow cytometry, respectively. Bioinformatic analysis was utilized to identify EV-related target proteins of piperine. RT-qPCR and Western blotting were performed to evaluate the expression of proapoptotic genes and proteins, respectively. Our findings demonstrated that piperine inhibited cell proliferation and induced apoptosis in both leukemic models. Cathepsin D (CTSD) has emerged as a piperine-responsive protein which was regulated apoptosis. Notably, EVs from piperine-treated leukemic cells upregulated CTSD and proapoptotic genes and proteins, Bax and caspase-3. These findings suggest that piperine modulates EV-mediated communication to promote apoptosis in acute leukemia. Interestingly, this work highlights the potential of piperine as a natural therapeutic agent targeting EV-mediated leukemic apoptosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.